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Wereportacaseofradiationﬁbrosisappearingasmass-likeconsolidation,whichwasdiﬃculttodistinguishfromlocalrecurrence.
A 72-year-old woman was diagnosed as having primary lung cancer (cT1N0M0 stage IA) in the right upper lobe and was treated
with SBRT of 48 Gy in 4 fractions. After 12 months, mass-like consolidation appeared around the irradiated area, and after 13
months, it had increased in size. FDG-PET revealed high uptake (SUV max = 5.61) for the consolidation. CT-guided biopsy was
performed, but we could not conﬁrm the diagnosis. Considering her poor respiratory function and her age, short-interval follow-
up was performed. After 15 months, the consolidation enlarged at the dorsal side, and carcinoembryonic antigen (CEA) became
elevated (14.6ng/mL). Serum KL-6 (436U/mL) and SP-D (204ng/mL) were also elevated. However, after 16 months, serum CEA
slightly decreased. The consolidation gradually retracted on follow-up CT images. CEA, KL-6, and SP-D were also decreased by
degrees. After 40 months, there is no evidence of local recurrence.
1.Introduction
Stereotacticbodyradiotherapy(SBRT)isaneﬀectivetherapy
for early-stage lung cancer. In some cases after SBRT,
dense consolidation is observed over or around the tumors
on follow-up computed tomography (CT). Sometimes, it
appearsasmass-likeconsolidation,inwhichcaseitisdiﬃcult
to distinguish radiation ﬁbrosis from local recurrence,
though it is important from a clinical point of view to make
this distinction.
We experienced a case of radiation ﬁbrosis appearing as
mass-like consolidation with elevation of serum carcinoem-
bryonic antigen (CEA), which was diﬃcult to distinguish
from local recurrence. In this paper, we present this case
along with a review of the literature.
2.CaseReport
A 72-year-old woman was diagnosed as having primary lung
cancer (cT1N0M0 stageA) of the right upper lobe (Figure 1).
Because her respiratory function was not suﬃcient for her
to undergo surgical resection, she was treated with SBRT.
Irradiation was performed with a 4-MV and 10-MV linear
accelerator. Forty-eight Gy in 4 fractions was prescribed
at the isocenter with multiple static ports. The isodose
distribution of SBRT is shown in Figure 2.S e r u mC E Aw a s
elevatedto14.7n/mL,butserumKL-6(230U/mL)andSP-D
(72.8ng/mL) were not elevated before SBRT. She was a heavy
smoker, and her Brinkman index was 900 (20 × 45 years).
F o l l o w - u pC Ts c a n sw e r ep e r f o r m e d2 ,6 ,9 ,a n d
12 months after SBRT. On CT images 2 months after
treatment, irregularly shaped patchy consolidation, which
was considered radiation pneumonitis, appeared in the
irradiated ﬁeld (Figure 3(a)). After 6 and 9 months, the
patchy consolidation was retracted, which was considered
to be typical radiation ﬁbrosis (Figures 3(b), 3(c)), and
serum CEA gradually decreased. However, after 12 months,
mass-like consolidation appeared around the irradiated area
(Figure 3(d)), and after 13 months, it had increased in size.2 Case Reports in Medicine
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Figure 1: CT images before SBRT showing a solitary lung tumor in
the right upper lobe.
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Figure 2: Dose distribution of treatment plan. The dashed line
indicates the 50% isodose curve.
Because ecstatic air-containing bronchi were not observed
within the consolidation, and the 3b branch of the right
lung was displaced on CT images, the possibility of local
recurrence was considered. At this time, serum CEA, KL-
6, and SP-D were not elevated compared with the previous
values. FDG-PET revealed high uptake (SUVmax = 5.61)
(a) (b)
(c) (d)
Figure 3: Serial CT images after SBRT. (a), (b), (c) CT images
at 2, 6, and 9 months after SBRT show irregularly shaped patchy
consolidation in the irradiated area. (d) CT images at 12 months
after SBRT showing the appearance of mass-like consolidation in
the irradiated area.
Figure 4: FDG-PET at 13 months after SBRT. High FDG uptake
(SUVmax = 5.61) was observed for the consolidation.
for the consolidation (Figure 4). CT-guided biopsy was
performed. The result of cytology was class II, and histolog-
i c a l l yc a n c e rc e l l sw e r en o td e t e c t e d .B e c a u s et h e r ew a sn o
deﬁnite evidence of malignancy, and considering her poor
respiratory function and her age, short-interval follow-up
was performed.
After 15 months, the consolidation enlarged at the dorsal
side, and serum CEA was elevated to 14.6ng/mL. Serum KL-
6 and SP-D were also elevated to 436U/mL and 204ng/mL,
respectively.However,after16months,serumCEAstartedto
decrease slightly. Furthermore, the consolidation graduallyCase Reports in Medicine 3
(a) (b) (c)
Figure 5: Serial CT images. (a) CT images at 15 months after SBRT show the mass-like consolidation enlarged at its dorsal side. (b), (c) CT
images at 18 and 27 months after SBRT show that the mass-like consolidation gradually retracted.
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Figure 6: Serial changes of serum CEA, KL-6, and SP-D. (1) At
12 months after SBRT, mass-like consolidation appeared in the
irradiated area. (2) At 15 months, the mass-like consolidation
enlarged at the dorsal side and serum CEA increased accompanied
by KL-6 and SP-D. (3) At 16 months, serum CEA was slightly
decreased. (4) At 31 months, minimal lung opacities suggesting
pneumonia in the left lower lobe were observed on CT images, but
no signiﬁcant change was seen in the irradiated area.
retracted on follow-up CT images (Figure 5). CEA, KL-6,
andSP-Ddecreasedbydegrees(Figure6),althoughtransient
re-elevation was observed after 31 months, accompanied by
the development of pneumonia in the left lower lung. At 40
months after the completion of SBRT, she is alive without
local recurrence.
3. Discussion
On CT images, parenchymal consolidation with a straight
lateral margin and air bronchograms is typical for radiation
ﬁbrosis, whereas a homogeneous opacity without air bron-
chograms and with a convex border is strongly suggestive
of recurrent tumor in the irradiated lung [1]. In addition,
the ﬁlling in of bronchi within radiation ﬁbrosis is abnormal
and usually represents local recurrent malignancy or a
superimposed infection [2]. Koenig et al. ﬁrstly described
as mass-like radiation ﬁbrosis related to 3-D conformal
radiotherapy [3]. Mass-like radiation ﬁbrosis in their cases
was accompanied by volume loss and bronchiectasis. How-
ever, in our case, neither volume loss nor bronchiectasis
was observed at the presence of mass-like consolidation.
Therefore,itwasdiﬃculttodiﬀerentiallydiagnosethismass-
like consolidation as radiation ﬁbrosis from local recurrence.
Aoki et al. [4] reported patchy consolidation or discrete
consolidation in 74% of cases during the ﬁrst 6 months after
SBRT. In SBRT, the shape of the dose distribution with a
lower dose tended to become large and irregular, while a
higher dose could be concentrated uniformly on the tumor.
Matsuo et al. [5] reported that mass-like consolidation
appeared in 27 (68%) of 40 tumors treated with SBRT.
Of these 27 mass-like consolidations, 24 were radiation-
induced lung injuries (RILI) and 3 were local recurrences.
According to the previous reports mentioned above, it is
not uncommon for mass-like consolidation to appear after
SBRT. In conventional radiation therapy, the shape of the
dose distribution of irradiated lungs is simple, and the
boundary between the nonirradiated and irradiated lung
is usually distinct [4]. In contrast, in SBRT, multiple non
coplanar portals with various directions were used. And the
dose distribution usually has a 3-D shape and concentrates
around the tumor. Therefore, radiation ﬁbrosis after SBRT
can appear in a 3-D shape, and is sometimes observed as
mass-like lesions. In our case, also, the consolidation after
SBRT had a 3-D shape, and was observed in approximately
50% or more of the isodose area.
Matsuo et al. [5] also reported that mass-like consoli-
dations appeared at a median of 5 months (range, 2 to 9
months) after SBRT. The time to the appearance of the mass-
like consolidations after SBRT was 2 to 9 months (median,4 Case Reports in Medicine
5 months) in RILI cases and 4 to 7 months (median, 7
months) in local recurrence cases. There was no signiﬁcant
diﬀerence in the time to appearance between RILI and local
recurrence. According to their report, the size of the mass-
like consolidations did not increase in any RILI cases after
12 months or later. In our case, however, the mass-like
consolidation appeared at 12 months after SBRT, and had
increased in size at 13 months. Radiation ﬁbrosis can appear
as mass-like consolidation even 12 months or more after the
completion of SBRT.
In our case, serum CEA was also elevated in addition
to the mass-like consolidation. The CEA elevation and
the late appearance of the mass-like consolidation made
it very diﬃcult to diﬀerentially diagnose this condition as
RILI from local recurrence. Several authors have reported
that CEA elevation is observed in patients with various
pulmonaryinﬂammationssuchasacutepneumonia,chronic
bronchitis,bronchialasthma,especiallyincaseswithmucoid
impaction, and idiopathic interstitial pneumonia [6–9]. In
our case, after 31 months, transient and slight re-elevation
of serum CEA was seen, accompanied by the elevation
of serum KL-6 and SP-D. CT examination at this time
revealed minimal lung opacities, suggesting the presence
of pneumonia in the left lower lobe, but no signiﬁcant
change in the irradiated area. This ﬁnding also suggested
that the transient CEA elevation after SBRT was related to
inﬂammatory changes of the lung in this case. The serum
CEA level of smokers has been reported to be higher than
that of nonsmokers [9]. CEA secretion from pulmonary
epithelial cells has been considered to be inﬂuenced by
smoking [10]. This patient was a heavy smoker, and serum
CEA did not decrease to its normal level after SBRT. The
elevation of the serum CEA level before SBRT may have
been caused not only by the tumor but also by heavy
smoking.
Serum KL-6 and SP-D are useful serum markers of
inﬂammatory lung diseases, typically interstitial pneumonia
[11]. It has also been reported that KL-6 and SP-D can
become elevated in some cases of adenocarcinoma [12].
In our case, however, serum KL-6 and SP-D levels were
not elevated before SBRT. Also, serial changes of these
serum marker levels were almost synchronous with the
radiological change of the consolidation after SBRT and
that following pneumonia in the left lower lung. There-
fore, the changes in the serum KL-6 and SP-D levels
after SBRT were considered to reﬂect the severity of the
pulmonary inﬂammation rather than the progression of
cancer.
4. Conclusion
We experienced a case of radiation ﬁbrosis appearing as
mass-like consolidation after SBRT with the elevation of
serum CEA, which was diﬃcult to distinguish from local
recurrence. If it is diﬃcult to make a deﬁnitive diagnosis
by further examination including FDG-PET and histological
examination, short-interval follow-up should be recom-
mended.
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